Sumitomo Mitsui Trust Group’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,896
Closed -$641K 1203
2022
Q4
$641K Sell
37,896
-552
-1% -$11K ﹤0.01% 1078
2022
Q3
$946K Sell
38,448
-254
-0.7% -$8.11K ﹤0.01% 1036
2022
Q2
$822K Sell
38,702
-1,179
-3% -$36.7K ﹤0.01% 1067
2022
Q1
$1.8M Hold
39,881
﹤0.01% 967
2021
Q4
$1.74M Hold
39,881
﹤0.01% 963
2021
Q3
$3.25M Hold
39,881
﹤0.01% 878
2021
Q2
$4.5M Hold
39,881
﹤0.01% 861
2021
Q1
$4.61M Hold
39,881
﹤0.01% 853
2020
Q4
$5.89M Hold
39,881
﹤0.01% 825
2020
Q3
$3.79M Sell
39,881
-938
-2% -$121K ﹤0.01% 836
2020
Q2
$5.39M Sell
40,819
-12,547
-24% -$1.53M ﹤0.01% 794
2020
Q1
$5.25M Hold
53,366
﹤0.01% 786
2019
Q4
$4.56M Hold
53,366
﹤0.01% 809
2019
Q3
$3.34M Buy
53,366
+36,189
+211% +$3.05M ﹤0.01% 819
2019
Q2
$2.16M Buy
17,177
+8,859
+107% +$1.67M ﹤0.01% 840
2019
Q1
$1.98M Buy
8,318
+8,259
+13,998% +$2.08M ﹤0.01% 796
2018
Q4
$14K Sell
59
-1
-2% -$252 ﹤0.01% 924
2018
Q3
$16K Buy
+60
New +$18K ﹤0.01% 898

Other funds holding VIVS

Sumitomo Mitsui Trust Group's VIVS Position: Q1 2023 in Review

Sumitomo Mitsui Trust Group sold out of VivoSim Labs (VIVS) in Q1 2023, closing a stake of 37,896 shares — an estimated $641K sold.

Sumitomo Mitsui Trust Group first reported a position in VIVS in Q3 2018 and held it in 18 quarters. The position peaked at $5.89M in Q4 2020. 35 funds tracked by Wall St. Rank hold VIVS as of Q1 2023.

  • Sumitomo Mitsui Trust Group reported no remaining VivoSim Labs position as of Q1 2023 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 37,896 VivoSim Labs shares in Q1 2023, an estimated $641K.
  • Sumitomo Mitsui Trust Group first reported a position in VivoSim Labs in Q3 2018 and held it in 18 quarters.
  • Sumitomo Mitsui Trust Group's VivoSim Labs position peaked at $5.89M in Q4 2020.
  • 35 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2023.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2023, filed 27 Apr 2023.